Gene · 4738
Papers3,078
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,078
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Native Semisynthesis of Isopeptide-Linked Substrates for Specificity Analysis of Deubiquitinases and Ubl Proteases. | J Am Chem Soc | 2023 | 37712884 | PubTator, text mining | PubMed |
| Methylation of the transcription factor E2F1 by SETD6 regulates SETD6 expression via a positive feedback mechanism. | J Biol Chem | 2023 | 37690684 | PubTator, text mining | PubMed |
| Neddylation inhibitor MLN4924 sensitizes head and neck squamous carcinoma cells to (S)-10-hydroxycamptothecin. | Eur J Med Res | 2023 | 37689760 | PubTator, text mining | PubMed |
| The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19. | Int J Mol Sci | 2023 | 37686182 | PubTator, text mining | PubMed |
| CRISPR/Cas9-mediated knockout of the ubiquitin variant UbKEKS reveals a role in regulating nucleolar structures and composition. | Biol Open | 2023 | 37670689 | PubTator, text mining | PubMed |
| UBE1C is upregulated and promotes neddylation of p53 in lung cancer. | FASEB J | 2023 | 37668436 | PubTator, text mining | PubMed |
| SUMOylation of the ubiquitin ligase component KEAP1 at K39 upregulates NRF2 and its target function in lung cancer cell proliferation. | J Biol Chem | 2023 | 37660919 | PubTator, text mining | PubMed |
| The NEDD8-activating enzyme E1 UBA3 orchestrates the immunosuppressive microenvironment in lung adenocarcinoma via the NF-кB pathway. | Med Oncol | 2023 | 37656220 | PubTator, text mining | PubMed |
| Activity-based profiling of cullin-RING E3 networks by conformation-specific probes. | Nat Chem Biol | 2023 | 37653169 | PubTator, text mining | PubMed |
| EEF2-inactivating toxins engage the NLRP1 inflammasome and promote epithelial barrier disruption. | J Exp Med | 2023 | 37642996 | PubTator, text mining | PubMed |
| FOXO1-regulated lncRNA CYP1B1-AS1 suppresses breast cancer cell proliferation by inhibiting neddylation. | Breast Cancer Res Treat | 2023 | 37640964 | PubTator, text mining | PubMed |
| Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal. | Genome Biol | 2023 | 37612728 | PubTator, text mining | PubMed |
| Tumor necrosis factor mediates USE1-independent FAT10ylation under inflammatory conditions. | Life Sci Alliance | 2023 | 37604583 | PubTator, text mining | PubMed |
| Fungal COP9 signalosome assembly requires connection of two trimeric intermediates for integration of intrinsic deneddylase. | Proc Natl Acad Sci U S A | 2023 | 37603767 | PubTator, text mining | PubMed |
| HER2-Low Breast Cancer: Current Landscape and Future Prospects. | Breast Cancer (Dove Med Press) | 2023 | 37600670 | PubTator, text mining | PubMed |
| The COP9 signalosome reduces neuroinflammation and attenuates ischemic neuronal stress in organotypic brain slice culture model. | Cell Mol Life Sci | 2023 | 37597109 | PubTator, text mining | PubMed |
| The ubiquitin-like modifier FAT10 covalently modifies HUWE1 and strengthens the interaction of AMBRA1 and HUWE1. | PLoS One | 2023 | 37578983 | PubTator, text mining | PubMed |
| Cross-family small GTPase ubiquitination by the intracellular pathogen Legionella pneumophila. | bioRxiv | 2023 | 37577546 | PubTator, text mining | PubMed |
| DCUN1D1 Is an Essential Regulator of Prostate Cancer Proliferation and Tumour Growth That Acts through Neddylation of Cullin 1, 3, 4A and 5 and Deregulation of Wnt/Catenin Pathway. | Cells | 2023 | 37566052 | PubTator, text mining | PubMed |
| The pharmacoepigenomic landscape of cancer cell lines reveals the epigenetic component of drug sensitivity. | Commun Biol | 2023 | 37558831 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4738/papers?page=14